The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Paul Vieira covers Canada for The Wall Street Journal, and is based in Ottawa.

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

The United States is already falling behind China in countless technological advancements, thanks to several Biden-era policies.

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

How valuable would it be to a company who manufactures vaccines if they had a product that the government mandated to be used on every animal? Even the chickens in your back yard? What if the bird flu ...

When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...